OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Interplay between Immunosenescence and Microbiota in the Efficacy of Vaccines
Rossella Cianci, Laura Franza, Maria Grazia Massaro, et al.
Vaccines (2020) Vol. 8, Iss. 4, pp. 636-636
Open Access | Times Cited: 24

Showing 24 citing articles:

The aging gut microbiome and its impact on host immunity
Nabil Bosco, Mario Noti
Genes and Immunity (2021) Vol. 22, Iss. 5-6, pp. 289-303
Open Access | Times Cited: 287

Mechanisms and Strategies of Immunosenescence Effects on Non-Small Cell Lung Cancer (NSCLC) Treatment: A Comprehensive Analysis and Future Directions
Huatao Zhou, Zilong Zheng, Chengming Fan, et al.
Seminars in Cancer Biology (2025) Vol. 109, pp. 44-66
Closed Access | Times Cited: 3

Host factors and vaccine efficacy: Implications for COVID‐19 vaccines
Shahab Falahi, Azra Kenarkoohi
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1330-1335
Open Access | Times Cited: 77

Gut Microbiota and Postbiotic Metabolites: Biotic Intervention for Enhancing Vaccine Responses and Personalized Medicine for Disease Prevention
Naheed Mojgani, Sumel Ashique, Mehran Moradi, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access | Times Cited: 1

Immune Memory in Aging: a Wide Perspective Covering Microbiota, Brain, Metabolism, and Epigenetics
Özlem Bulut, Gizem Kılıç, Jorge Domínguez‐Andrés
Clinical Reviews in Allergy & Immunology (2021) Vol. 63, Iss. 3, pp. 499-529
Open Access | Times Cited: 31

Effectiveness of Multistrain Probiotic Formulation on Common Infectious Disease Symptoms and Gut Microbiota Modulation in Flu-Vaccinated Healthy Elderly Subjects
Anna Sandionigi, Alessandra De Giani, Francesco Tursi, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 21

Long-Term Exposure to Air Pollution and COVID-19 Vaccine Antibody Response in a General Population Cohort (COVICAT Study, Catalonia)
Manolis Kogevinas, Marianna Karachaliou, Ana Espinosa, et al.
Environmental Health Perspectives (2023) Vol. 131, Iss. 4
Open Access | Times Cited: 12

Factors Influencing Microbiota in Modulating Vaccine Immune Response: A Long Way to Go
Francesca Romana Ponziani, Gaetano Coppola, Pierluigi Rio, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1609-1609
Open Access | Times Cited: 11

Intestinal Microbiota and Its Effect on Vaccine-Induced Immune Amplification and Tolerance
Yixin Liu, Jianfeng Zhou, Yu‐Shang Yang, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 868-868
Open Access | Times Cited: 4

Effects of Early-Life Air Pollution Exposure on Childhood COVID-19 Infection and Sequelae in China
Chan Lu, Wen Deng, Zipeng Qiao, et al.
Journal of Hazardous Materials (2025), pp. 137940-137940
Closed Access

Older adults: panoramic view on the COVID-19 vaccination
B. G. Andryukov, Natalya N. Besednova
AIMS Public Health (2021) Vol. 8, Iss. 3, pp. 388-415
Open Access | Times Cited: 22

SARS-CoV-2 Vaccines: Types, Working Principle, and Its Impact on Thrombosis and Gastrointestinal Disorders
Shubhra Khare, Niharika Niharika, Ajey Singh, et al.
Applied Biochemistry and Biotechnology (2022) Vol. 195, Iss. 2, pp. 1541-1573
Open Access | Times Cited: 15

Efficacy of the tetravalent protein COVID-19 vaccine, SCTV01E: a phase 3 double-blind, randomized, placebo-controlled trial
Ruizhi Zhang, Junshi Zhao, Xiaoping Zhu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3

Vaccines, Microbiota and Immunonutrition: Food for Thought
Laura Di Renzo, Laura Franza, Diego Monsignore, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 294-294
Open Access | Times Cited: 14

Pollution, Inflammation, and Vaccines: A Complex Crosstalk
Laura Franza, Rossella Cianci
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 12, pp. 6330-6330
Open Access | Times Cited: 17

Effect of COVID-19 Vaccination on the In-Hospital Prognosis of Patients Admitted during Delta and Omicron Waves in Italy
Rossella Cianci, Laura Franza, Giulia Pignataro, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 373-373
Open Access | Times Cited: 5

How does geographical diversity shape vaccine efficacy?
Mohammad Abavisani, Bahareh Ansari, Negar Ebadpour, et al.
Clinical and Experimental Vaccine Research (2024) Vol. 13, Iss. 4, pp. 271-271
Open Access | Times Cited: 1

Advances in Vaccine Development
Ralph A. Tripp
Vaccines (2021) Vol. 9, Iss. 9, pp. 1036-1036
Open Access | Times Cited: 4

The Ageing Microbiome, Pharmaceutical Considerations, and Therapeutic Opportunities
Alessia Favaron, Laura E. McCoubrey, Moe Elbadawi, et al.
AAPS advances in the pharmaceutical sciences series (2023), pp. 191-230
Closed Access | Times Cited: 1

Adjuvants, immunomodulators, and adaptogens
Anita Milicic, Sören Reinke, Joannah R. Fergusson, et al.
Elsevier eBooks (2022), pp. 223-280
Closed Access | Times Cited: 2

Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World
Rossella Cianci, Laura Franza
Vaccines (2020) Vol. 9, Iss. 1, pp. 9-9
Open Access | Times Cited: 2

Page 1

Scroll to top